Real world prevalence of pelvic lymph node involvement in prostate cancer in Asia: do we need a rethink on normograms?
IntroductionThe Briganti 2019 nomogram stratifies risk of lymph node involvement (LNI) in prostate cancer, reducing unnecessary pelvic lymph node dissection (PLND) during radical prostatectomy (RP). However the applicability of the nomogram in diverse populations remains under-explored, with only on...
Saved in:
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-05-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1583806/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849325262293958656 |
|---|---|
| author | Rachel Lau Han Jie Lee Khi Yung Fong Alvin Yuanming Lee Yu Guang Tan Yan Mee Law Nye Thane Ngo Jeffrey Tuan Kae Jack Tay Lui Shiong Lee Christopher Cheng Henry Ho John Yuen Kenneth Chen |
| author_facet | Rachel Lau Han Jie Lee Khi Yung Fong Alvin Yuanming Lee Yu Guang Tan Yan Mee Law Nye Thane Ngo Jeffrey Tuan Kae Jack Tay Lui Shiong Lee Christopher Cheng Henry Ho John Yuen Kenneth Chen |
| author_sort | Rachel Lau |
| collection | DOAJ |
| description | IntroductionThe Briganti 2019 nomogram stratifies risk of lymph node involvement (LNI) in prostate cancer, reducing unnecessary pelvic lymph node dissection (PLND) during radical prostatectomy (RP). However the applicability of the nomogram in diverse populations remains under-explored, with only one external validation study performed in an Asian population to date. We aim to evaluate the performance of the nomogram in a large tertiary Asian institution.MethodsA retrospective cohort study was conducted, with analysis of the cancer registry in our tertiary institution of all patients who underwent RP with PLND between 1988 and 2023. The Briganti 2019 nomogram score was retrospectively calculated for each patient, and post-operative data was analyzed to determine rates of LNI in order to determine the performance of the nomogram in our cohort.Results437 patients were included, with a median Briganti score of 11.2% (IQR 3.9–28.5%). The mean number of lymph nodes excised per patient was 15.1±12. 292 (66.8%) patients had a Briganti score greater than 7%, but only 8.6% were noted to harbor pN1 disease after RP. In our Asian cohort, the 2019 Briganti nomogram only had a moderate discriminatory ability with an area under the receiver operating characteristic curve (AUC) of 0.77. On multivariate analysis, independent predictors of LNI in our population included percentage of positive biopsy cores [Odds Ratio (OR) 1.02, 95%CI 1.01–1.04, p=0.01] and extraprostatic extension on MRI prostate (OR 3.00, 95%CI 1.20–7.56, p=0.02).ConclusionThe Briganti 2019 nomogram, while effective in many settings, only had a moderate ability to identify patients with pN1 disease in our Asian cohort. With potential limitations in its generalizability to multiple populations, a re-evaluation of its thresholds and further calibration to other populations might be required. |
| format | Article |
| id | doaj-art-97b53ff68fec4575a0522ac95a382eb9 |
| institution | Kabale University |
| issn | 2234-943X |
| language | English |
| publishDate | 2025-05-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Oncology |
| spelling | doaj-art-97b53ff68fec4575a0522ac95a382eb92025-08-20T03:48:27ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2025-05-011510.3389/fonc.2025.15838061583806Real world prevalence of pelvic lymph node involvement in prostate cancer in Asia: do we need a rethink on normograms?Rachel Lau0Han Jie Lee1Khi Yung Fong2Alvin Yuanming Lee3Yu Guang Tan4Yan Mee Law5Nye Thane Ngo6Jeffrey Tuan7Kae Jack Tay8Lui Shiong Lee9Christopher Cheng10Henry Ho11John Yuen12Kenneth Chen13Department of Urology, Singapore General Hospital, Singapore, SingaporeDepartment of Urology, Singapore General Hospital, Singapore, SingaporeDepartment of Urology, Singapore General Hospital, Singapore, SingaporeDepartment of Urology, Singapore General Hospital, Singapore, SingaporeDepartment of Urology, Singapore General Hospital, Singapore, SingaporeDepartment of Diagnostic Radiology, Singapore General Hospital, Singapore, SingaporeDepartment of Pathology, Singapore General Hospital, Singapore, SingaporeDivision of Radiation Oncology, National Cancer Centre Singapore, Singapore, SingaporeDepartment of Urology, Singapore General Hospital, Singapore, SingaporeDepartment of Urology, Sengkang General Hospital, Singapore, SingaporeDepartment of Urology, Singapore General Hospital, Singapore, SingaporeDepartment of Urology, Singapore General Hospital, Singapore, SingaporeDepartment of Urology, Singapore General Hospital, Singapore, SingaporeDepartment of Urology, Singapore General Hospital, Singapore, SingaporeIntroductionThe Briganti 2019 nomogram stratifies risk of lymph node involvement (LNI) in prostate cancer, reducing unnecessary pelvic lymph node dissection (PLND) during radical prostatectomy (RP). However the applicability of the nomogram in diverse populations remains under-explored, with only one external validation study performed in an Asian population to date. We aim to evaluate the performance of the nomogram in a large tertiary Asian institution.MethodsA retrospective cohort study was conducted, with analysis of the cancer registry in our tertiary institution of all patients who underwent RP with PLND between 1988 and 2023. The Briganti 2019 nomogram score was retrospectively calculated for each patient, and post-operative data was analyzed to determine rates of LNI in order to determine the performance of the nomogram in our cohort.Results437 patients were included, with a median Briganti score of 11.2% (IQR 3.9–28.5%). The mean number of lymph nodes excised per patient was 15.1±12. 292 (66.8%) patients had a Briganti score greater than 7%, but only 8.6% were noted to harbor pN1 disease after RP. In our Asian cohort, the 2019 Briganti nomogram only had a moderate discriminatory ability with an area under the receiver operating characteristic curve (AUC) of 0.77. On multivariate analysis, independent predictors of LNI in our population included percentage of positive biopsy cores [Odds Ratio (OR) 1.02, 95%CI 1.01–1.04, p=0.01] and extraprostatic extension on MRI prostate (OR 3.00, 95%CI 1.20–7.56, p=0.02).ConclusionThe Briganti 2019 nomogram, while effective in many settings, only had a moderate ability to identify patients with pN1 disease in our Asian cohort. With potential limitations in its generalizability to multiple populations, a re-evaluation of its thresholds and further calibration to other populations might be required.https://www.frontiersin.org/articles/10.3389/fonc.2025.1583806/fullprostate cancernomogramslymph node involvementnormogramsradical prostatectomylymph node staging |
| spellingShingle | Rachel Lau Han Jie Lee Khi Yung Fong Alvin Yuanming Lee Yu Guang Tan Yan Mee Law Nye Thane Ngo Jeffrey Tuan Kae Jack Tay Lui Shiong Lee Christopher Cheng Henry Ho John Yuen Kenneth Chen Real world prevalence of pelvic lymph node involvement in prostate cancer in Asia: do we need a rethink on normograms? Frontiers in Oncology prostate cancer nomograms lymph node involvement normograms radical prostatectomy lymph node staging |
| title | Real world prevalence of pelvic lymph node involvement in prostate cancer in Asia: do we need a rethink on normograms? |
| title_full | Real world prevalence of pelvic lymph node involvement in prostate cancer in Asia: do we need a rethink on normograms? |
| title_fullStr | Real world prevalence of pelvic lymph node involvement in prostate cancer in Asia: do we need a rethink on normograms? |
| title_full_unstemmed | Real world prevalence of pelvic lymph node involvement in prostate cancer in Asia: do we need a rethink on normograms? |
| title_short | Real world prevalence of pelvic lymph node involvement in prostate cancer in Asia: do we need a rethink on normograms? |
| title_sort | real world prevalence of pelvic lymph node involvement in prostate cancer in asia do we need a rethink on normograms |
| topic | prostate cancer nomograms lymph node involvement normograms radical prostatectomy lymph node staging |
| url | https://www.frontiersin.org/articles/10.3389/fonc.2025.1583806/full |
| work_keys_str_mv | AT rachellau realworldprevalenceofpelviclymphnodeinvolvementinprostatecancerinasiadoweneedarethinkonnormograms AT hanjielee realworldprevalenceofpelviclymphnodeinvolvementinprostatecancerinasiadoweneedarethinkonnormograms AT khiyungfong realworldprevalenceofpelviclymphnodeinvolvementinprostatecancerinasiadoweneedarethinkonnormograms AT alvinyuanminglee realworldprevalenceofpelviclymphnodeinvolvementinprostatecancerinasiadoweneedarethinkonnormograms AT yuguangtan realworldprevalenceofpelviclymphnodeinvolvementinprostatecancerinasiadoweneedarethinkonnormograms AT yanmeelaw realworldprevalenceofpelviclymphnodeinvolvementinprostatecancerinasiadoweneedarethinkonnormograms AT nyethanengo realworldprevalenceofpelviclymphnodeinvolvementinprostatecancerinasiadoweneedarethinkonnormograms AT jeffreytuan realworldprevalenceofpelviclymphnodeinvolvementinprostatecancerinasiadoweneedarethinkonnormograms AT kaejacktay realworldprevalenceofpelviclymphnodeinvolvementinprostatecancerinasiadoweneedarethinkonnormograms AT luishionglee realworldprevalenceofpelviclymphnodeinvolvementinprostatecancerinasiadoweneedarethinkonnormograms AT christophercheng realworldprevalenceofpelviclymphnodeinvolvementinprostatecancerinasiadoweneedarethinkonnormograms AT henryho realworldprevalenceofpelviclymphnodeinvolvementinprostatecancerinasiadoweneedarethinkonnormograms AT johnyuen realworldprevalenceofpelviclymphnodeinvolvementinprostatecancerinasiadoweneedarethinkonnormograms AT kennethchen realworldprevalenceofpelviclymphnodeinvolvementinprostatecancerinasiadoweneedarethinkonnormograms |